IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 301 - 320 of 1312 stories.
February 17, 2014
Novartis announced today that it is buying CoStim Pharmaceuticals (Cambridge, MA), a privately held biotechnology company focused on harnessing the immune system to eliminate...
February 12, 2014
Cedarburg Hauser Pharmaceuticals (CHP; Grafton, WI), a contract development and manufacturing organization specializing in small molecule active pharmaceutical ingredients (APIs), says...
February 12, 2014
The active pharmaceutical ingredient (API) business of Aurobindo Pharma (Hyderabad, India) reports a 12.7% rise in sales in the company’s fiscal third quarter, ended 31 December...
February 11, 2014
The pharmaceutical services and active ingredients (PSAI) business of Dr. Reddy’s Laboratories (Hyderabad, India) reports a 29% fall in sales in the company’s fiscal third...
February 11, 2014
Cambrex (East Rutherford, NJ) reports a 79.6% fall in net profits for the fourth quarter of 2013, ended 31 December, compared with the year-ago quarter, to $8.89 million. The results...
February 11, 2014
Jazz Pharmaceuticals (Dublin), a specialty biopharmaceutical company, on Monday held a ground breaking ceremony for a €45–50 million ($60-68 million) manufacturing and...
February 11, 2014
Teva’s API business reports fall in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel) reports a 19.3% fall in...
February 7, 2014
The active pharmaceutical ingredient (API) business of Ranbaxy Laboratories (Gurgaon, India) reports sales of 1.37 billion Indian rupees ($22 million) in the fourth quarter of 2013...
February 7, 2014
The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel) reports a 19.3% fall in sales in the fourth quarter of 2013, compared with...
February 5, 2014
FMC today reported fourth-quarter earnings down 73.5% year-on-year (YOY), to $27.1 million, or 20 cts/share, on sales up 24%, to $1.1 billion. Earnings were hit by $114.3 million in...
February 4, 2014
Johnson Matthey appoints new CEO, fine chemicals sales up Johnson Matthey announced the appointment of its new CEO and reported the third-quarter results, covering 1 October 2013...
January 28, 2014
Albemarle today reported fourth-quarter adjusted earnings of $88.4 million, or $1.08/share, down 16% year-on-year (YOY), but ahead of analysts' consensus estimate of $1.04/share as...
January 28, 2014
Informex 2014: Rising certainty despite challenges for pharma Attendees and exhibitors at this year's Informex USA, held last week in Miami Beach, were mostly optimistic about the...
January 24, 2014
The US Food and Drug Administration (FDA) announced on 23 January that it has notified Ranbaxy Laboratories (Gurgaon, India), that it is prohibited from manufacturing and distributing...
January 23, 2014
Attendees and exhibitors at this year's Informex USA, held this week in Miami Beach, were mostly optimistic about the direction of the fine chemicals and contract manufacturing...
January 23, 2014
Lonza recorded a 44.2% fall in profits for 2013 compared with 2012, to 87 million Swiss francs ($95.7 million). Sales for 2013 decreased by 4.2%, to SF3.58 billion, due to lower sales...
January 22, 2014
Reform of the Toxic Substances Control Act (TSCA), along with trade-related issues, are the top regulatory concerns at Informex this year, attendees and exhibitors say. Socma's number...
January 21, 2014
The Excipact Association, a project of the IPEC Federation (Brussels), says that Sepiprod (Castres, France) has received an Excipact certification from mdc medical device...
January 21, 2014
Feature Antibody-drug conjugates: A developing market with substantial growth potential The antibody-drug conjugates (ADCs) market, which is in its early stages of development, offers...
January 20, 2014
Aurobindo Pharma (Hyderabad, India) says it will acquire the commercial operations of Actavis (Dublin) in seven Western European countries. Aurobindo will acquire Actavis'...
Pages: « Previous  7 8 9 10 11 12 13 14 15 [16] 17 18 19 20 21 22 23 24 25 Next »

contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa